Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
1 - 10 out of 502Page size: 10
  1. 2024
  2. Published

    Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled study

    Sivalingam, S., Wasehuus, V. S., Rotbain Curovic, V., Blond, Martin Bæk, Hansen, T. W., Persson, F. & Rossing, Peter, 2024, In: Diabetes, Obesity and Metabolism. 26, 1, p. 54-64 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial

    Bornstein, S. R., de Zeeuw, D., Heerspink, H. J. L., Schulze, F., Cronin, L., Wenz, A., Tuttle, K. R., Hadjadj, S. & Rossing, Peter, 2024, (E-pub ahead of print) In: Diabetes, Obesity and Metabolism.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Association of carpal tunnel syndrome with incident diabetes

    Jacobsen, J. R., Westergaard, L. M., Fosbøl, E. L., Kristensen, S. L., Køber, Lars Valeur, Persson, F., Rossing, Peter & Rørth, R., 2024, (E-pub ahead of print) In: Diabetes, Obesity and Metabolism.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

    Schnell, O., Barnard-Kelly, K., Battelino, T., Ceriello, A., Larsson, H. E., Fernández-Fernández, B., Forst, T., Frias, J. P., Gavin, J. R., Giorgino, F., Groop, P. H., Heerspink, H. J. L., Herzig, S., Hummel, M., Huntley, G., Ibrahim, M., Itzhak, B., Jacob, S., Ji, L., Kosiborod, M. & 23 others, Lalic, N., Macieira, S., Malik, R. A., Mankovsky, B., Marx, N., Mathieu, C., Müller, T. D., Ray, K., Rodbard, H. W., Rossing, Peter, Rydén, L., Schumm-Draeger, P. M., Schwarz, P., Škrha, J., Snoek, F., Tacke, F., Taylor, B., Jeppesen, B. T., Tesfaye, S., Topsever, P., Vilsbøll, Tina, Yu, X. & Standl, E., 2024, In: Cardiovascular Diabetology. 23, 1, 17 p., 104.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  6. Published

    Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes

    Sridhar, V. S., Limonte, C. P., Groop, P. H., Heerspink, H. J. L., Pratley, R. E., Rossing, Peter, Skyler, J. S. & Cherney, D. Z. I., 2024, In: Diabetologia. 67, 1, p. 3-18 16 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Copenhagen Diabetes Consensus (CODIAC) 2021: User involvement in diabetes care, prevention and research

    Bloch, P., Dadaczynski, K., Grabowski, D., Lomborg, K., Olesen, K., Rasmussen, Lauge Neimann, Rossing, Peter, Varming, A., Willaing, I., Harris, J., Holt, R. I. G. & Jensen, B. B., 2024, In: Diabetic Medicine. 41, 1, 11 p., e15160.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria

    Heerspink, H. J. L., Provenzano, M., Vart, P., Jongs, N., Correa-Rotter, R., Rossing, Peter, Mark, P. B., Pecoits-Filho, R., McMurray, J. J. V., Langkilde, A. M., Wheeler, D. C., Toto, R. B. & Chertow, G. M., 2024, In: American Heart Journal. 270, p. 125-135 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial

    McEwan, P., Davis, J. A., Gabb, P. D., Wheeler, D. C., Rossing, Peter, Chertow, G. M., Correa-Rotter, R., Tamura, K., Barone, S. & Sanchez, J. J. G., 2024, In: Clinical Kidney Journal. 17, 2, 13 p., sfae025.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Effect of dapagliflozin on collectins and complement activation in plasma from patients with type 2 diabetes and albuminuria: Data from the DapKid cohort

    Jensen, M., Eickhoff, M. K., Persson, F., Rossing, Peter, Thiel, S., Hansen, S. W. K., Palarasah, Y., Svenningsen, P. & Jensen, B. L., 2024, In: Immunobiology. 229, 3, 6 p., 152797.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Efficacy and Safety of Dapagliflozin in Patients with Chronic Kidney Disease across the Spectrum of Frailty

    Vart, P., Butt, J. H., Jongs, N., Schechter, M., Chertow, G. M., Wheeler, D. C., Pecoits-Filho, R., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, McMurray, J. J. V. & Heerspink, H. J. L., 2024, In: Journals of Gerontology. Series A: Biological Sciences & Medical Sciences. 79, 2, 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...51 Next

ID: 12937790